Skip to main content
. 2018 Jan 29;15(4):3302–3310. doi: 10.3892/etm.2018.5804

Figure 2.

Figure 2.

(A) Changes in mouse body weights prior to and following BSHXF administration. Prior to modeling, the weights of the mice in the control, model and BSHXF-treated groups were 21.024±1.353, 20.700±1.287 and 20.588±1.113 (P>0.05). Following modeling, the body weights were markedly reduced in the model group compared with the control. At the end of the 6-week experimental period, the body weights were 24.108±0.861, 23.612±0.564 and 22.984±0.903 for the control, model and BSHXF-treated groups, respectively, and the body weight in the model group was significantly decreased compared with that in the control and BSHXF-treated groups (P<0.01). (B) Changes of organ indices prior to and following BSHXF administration. The index values in the control, model and BSHXF-treated groups were: Thymus index: 2.619±0.371, 2.220±0.235 and 2.400±0.305 mg; spleen index: 3.543±0.227, 3.767±0.476 and 3.520±0.409 mg; uterus index: 3.561±0.149, 2.854±0.825 and 3.018±0.640 mg; ovary index: 0.498±0.164, 0.382±0.043 and 0.465±0.137 mg. *P<0.05 and **P<0.01 vs. the control group; ##P<0.01 vs. the model group. BSHXF, Bu Shen Huo Xue formula.